Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages

  Donohoe, Helen ^a  

^a Self Management Working Group   (United Kingdom)

Author keywords

Asthma; Patient information; Patient perceptions; Professional education; Self management

Indexed keywords

CHLOROFLUOROCARBON;

ASTHMA; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH SERVICE; METERED DOSE INHALER; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

EID: 0033433953     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70038-2     Document Type: Review

References (6)

1. 1. The Asthma Audit 1999-2000. National Asthma Campaign 1999. National Asthma Campaign, UK, Providence House, Providence Place, London, NI ONT, UK.
2. 2. Odd R. New inhalers: "biggest change ever." The Pharmaceutical Journal 1998;260-96.
3. 3. Craven A. All changed. Community Outlook. February 13, 1985:31-3.
4. 4. Dowell JS, Snadden D, Dunhar JA. Changing to generic formulary: how one fundholding practice reduced prescribing costs. Br Med J 1995; 310:505-8.
5. 5. National Asthma Campaign CFC-free Inhaler Survey 1997 conducted by OMSI Ltd, 4741 respondents. National Asthma Campaign, UK, Providence House, Providence Place, London, NI ONT, UK.
6. 6. Weinstein AG. Noncompliance with asthma is a common cause of treatment failure. Ann Allergy Asthma Immunol 1995;74: 304-10.